About

In 1903, The Peacocks Group LTD began its journey, founded under the name J.C Peacock and Son LTD (John Clint Peacock). A lucrative cutlery manufacturer that would experience many successful years in that business.

1914 saw the beginning of our journey through British health care, as J.C. Peacock and Son Ltd saw the devastating effects of the Great War and turned to focus on manufacturing surgical equipment and providing instruments and splints.

Founder and first-generation leader, John Clint Peacock (JC), passed the business to his eldest son, Leslie Peacock. However, both passed away suddenly, leaving the business to the younger son, Roy Peacock (2nd generation, circa 1928). Roy closely collaborated with the Founders of the new NHS services and established business arrangements to provide services in the North East of England.

Peacocks began work with the newly formed NHS. Thus, a highly successful continuous partnership was born.

Peacocks SME is launched in 1956 to the Medical + Dental market. Specialising in ground-breaking decontamination and sterilisation equipment to hospitals, surgeries, and clinics. Making surgical environments cleaner, safer, better.

Colin Peacock worked closely with BHTA, collaborating to develop the first recognised University qualification in Orthotics.

In 1988, Peacocks Medical Group proudly opened its Southampton branch, marking a significant expansion of our healthcare services to the Southampton community. This represented a major step forward to becoming a truly nationwide company.

Continuing our collaboration with ORLAU, Peacocks played a pivotal role in developing the concept of low load prolonged stretch for contracture correction. This effort culminated in the publication of "Preliminary clinical experience of a contracture correction device" in an international journal.

A-FOOTPRINT aimed to develop and validate additive manufacturing as a new technology for custom orthoses. This European research project brought together experts from clinical services, academia, and industry to research the best way forward in bringing the latest technology to orthotic provision. The Peacocks Group played a pivotal role as a key partner in this four-year project.

The Peacocks Group was a partner in the European Horizons training programme on Knee Arthritis helping train and develop researchers of the future.

After years of research, rigorous mechanical tests, and clinical validation, PODFO was launched in 2015. PODFO's are custom orthoses that utilise additive manufacturing technology. PODFO was the world’s first 3D printed customer insole - Developed as a direct result of the learning from the A-Footprint project, PODFO's brings innovative research to clinical practice for the benefit of patients.

In 2022, we introduced CURO, a pioneering solution addressing the financial and environmental challenges of clinical waste in the NHS. As the exclusive end-to-end sustainable innovation for clinical waste, CURO is reshaping how the NHS manage this critical issue.

Peacocks thrives on growth and innovation, expanding across the UK. Our customer-centric culture priorities solutions and CSR values, while groundbreaking innovations like PODFO and CURO drive market change.